Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New market study, "Trinity Biotech Plc (TRIB) - Product Pipeline Analysis", has been published


Print article Print article
2012-09-07 05:39:05 - New Medical Devices research report from GlobalData is now available from Fast Market Research

Trinity Biotech Plc (Trinity Biotech) is a diagnostic products manufcaturer. The company develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company categorizes its products into Clinical Laboratory and Point-of-care. The Clinical Laboratory products include diagnostic tests and instruments that detect infectious diseases, HbA1c for diabetes monitoring and diagnosis, and clinical chemistry. Its Point-of-care products are for testing the presence of HIV antibodies. The products are used for the detection of autoimmune, sexually tranmitted diseases, infectious diseases, diabetes, liver disorder and intestine disorder. The company also offers raw materials to the life sciences industry. It markets its products through direct sales in the US, Germany, France and the UK; and through a network of distributors

and strategic partnerships in other countries. The company has its manufacturing facilities located at the US and Ireland. Trinity Biotech is headquartered in Co Wicklow, Ireland.


Full Report Details at
- www.fastmr.com/prod/456416_trinity_biotech_plc_trib_product_pipe ..


The company focuses on expanding and strengthening its point-of-care products through the acquisition of Fiomi Diagnostics AB. Trinity Biotech leverages on the research and development platform of Fiomi to develop next generation multiplexed, infectious disease assays.

This report is a source for data, analysis and actionable intelligence on the Trinity Biotech Plc portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.
* Exploit M&A opportunities by identifying market players with the most innovative pipeline.
* Develop market-entry and market expansion strategies.
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
* Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
* Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser